There are 444 papers on Tau in aging research: 17 trials and 231 observational studies in people, 50 in animals, 2 in cells, 135 reviews. The newest story, Nov 12, 2026: “Spinal-fluid protein linked to Alzheimer’s progression”.
A human study links tau with Alzheimer's disease progression; human cohorts link it with worse cognition and, in people with elevated amyloid, worse everyday functioning. A human trial reports lower tau with a modified Mediterranean-ketogenic diet; a preprint trial reports no clear effect of low-dose rapamycin in APOE4 carriers or non-carriers.
77 findings in 67 papers from 2013 to 2026, 12 of them since April 2026
“Genetic correlation and polygenic overlap analyses indicate a common underlying genetic mechanism between the ALPS-index, ventricular volumes, and cerebrospinal fluid tau levels”
Dasatinib + quercetin showed no clear effect on Tau in humans.
“The phosphorylated tau occupancy at different tau residues (pT111/T111, pT153/T153, pT181/T181, pS199/S199, pT205/T205, pS208/S208, pT217/T217, pT231/T231), as well as the levels of microtubule binding region (MTBR) for tau 212–221 (MTBR-tau212–221) and tau 243–254 (MTBR-tau243–254, an indicator of tau tangles) displayed no statistically significant changes across time points (Supplementary Figure 2 a-j and Supplementary Table 1”
Tau is linked with worse cognitive function in humans (preclinical Alzheimer's disease).
“Greater MTL and NEO tau deposition were also associated with greater decline in MTB‐composite scores (Time*MTL tau: β = ‐0.30, 95%CI[‐0.48 – ‐0.13], p =.001”
Tau is linked with cognitive function in humans (cognitively unimpaired) (indirect effect β = -0.068; 95 % CI [-0.126, -0.011]).
“Mediation analysis indicated that tau deposition significantly mediated the association between PP and cognitive decline (indirect effect β = -0.068; 95 % CI [-0.126, -0.011]).”
Tau is linked with lower amygdalar pattern similarity in older adults without dementia below standard positivity thresholds.
“Greater tau levels in the entorhinal cortex and amygdalae were associated with less pattern similarity in left amygdalar reactivity to negative and neutral images”
Humansin older adults without dementia below standard positivity thresholdsentorhinal cortex
Tau is linked with higher driving unpredictability in humans (tau+ vs tau-).
“tau+ participants exhibited slower declines in SBSOD and greater increases in driving unpredictability (i.e., higher entropy, greater percentages of chained trips/distances) across 5.6 years”
Tau is linked with worse everyday functioning in individuals with elevated amyloid.
“Among individuals with elevated amyloid, those with the highest levels of neocortical and medial temporal tau showed the largest decline in everyday functioning”
Humansin individuals with elevated amyloidn = 1,707
Tau raises the risk of Alzheimer's disease in humans (effect size 2.10).
“High tau (effect size 2.10, 95% CI, I2 = 52%), and p-tau (1.95, I2 = 48%), and a decrease in Ab42 (1.75, I2 = 45%), were each found to have a consistent positive relation with an increased risk of Alzheimer's disease.”
Parietal periodic gamma power is associated with Tau in humans (beta-amyloid-positive adults) (beta = +0.90, p = 0.002 in the entorhinal cortex).
“in beta-amyloid-positive adults, higher periodic gamma was associated with higher MTL tau, most strongly in the entorhinal cortex (beta = +0.90, p = 0.002)”
Tau is associated with hippocampal-retrosplenial connectivity in humans (retrosplenial tau burden).
“Retrosplenial tau burden was associated with higher hippocampal-retrosplenial connectivity consistent with tau spread along canonical hippocampal output pathways.”
“Higher levels of valine were associated with greater total white matter and posterior cingulate cortex volumes, as well as with lower levels of CSF tau proteins.”
Intraindividual cognitive variability predicts Tau in humans (Down syndrome).
“Greater IICV predicted incident MCI/dementia (odds ratio = 4.63 to 5.13, p < 0.05), greater amyloid burden, early tau accumulation, and higher tau across Braak stages”
Higher levels of one spinal-fluid protein were linked to greater dementia risk, with a hazard ratio of 1.325, a measure of relative risk.Higher levels of one spinal-fluid protein were linked to greater dementia risk, with a hazard ratio of 1.325, a measure of relative risk.